<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05016921</url>
  </required_header>
  <id_info>
    <org_study_id>849193</org_study_id>
    <nct_id>NCT05016921</nct_id>
  </id_info>
  <brief_title>TcMS to Treat Ventricular Tachycardia</brief_title>
  <official_title>Transcutaneous Magnetic Stimulation of the Stellate Ganglion to Treat Ventricular Tachycardia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open label study of transcutaneous magnetic stimulation targeting the stellate ganglion in&#xD;
      patients with ventricular tachycardia&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">January 2026</completion_date>
  <primary_completion_date type="Anticipated">January 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ventricular Tachycardia</measure>
    <time_frame>0-72 hours after enrollment</time_frame>
    <description>Burden (number of episodes) of ventricular tachycardia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Non sustained ventricular tachycardia</measure>
    <time_frame>0-72 hours after enrollment</time_frame>
    <description>Burden (number of episodes) of ventricular tachycardia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discomfort</measure>
    <time_frame>Assessed immediately following stimulation</time_frame>
    <description>Discomfort experienced during stimulation (on scale of 0-10) reported by patient</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Ventricular Tachycardia</condition>
  <arm_group>
    <arm_group_label>Transcutaneous magnetic stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transcutaneous magnetic stimulation targeting the stellate ganglion</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TcMS</intervention_name>
    <description>Transcutaneous magnetic stimulation targeting the stellate ganglion</description>
    <arm_group_label>Transcutaneous magnetic stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;18years&#xD;
&#xD;
          -  Documented ventricular tachycardia within the preceding 72 hours&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Implanted ventricular assist device&#xD;
&#xD;
          -  Metal implanted in heard or neck (except the mouth)&#xD;
&#xD;
          -  Implanted medication pumps&#xD;
&#xD;
          -  Cochlear implant&#xD;
&#xD;
          -  Implanted brain stimulator&#xD;
&#xD;
          -  Ocular implant&#xD;
&#xD;
          -  History of malignancy in the region of stimulation (neck)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Timothy Markman, MD</last_name>
    <phone>2675930103</phone>
    <email>timothy.markman@pennmedicine.upenn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 16, 2021</study_first_submitted>
  <study_first_submitted_qc>August 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 23, 2021</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

